Sex-Divergent Clinical Outcomes and Precision Medicine: An Important New Role for Institutional Review Boards and Research Ethics Committees
The efforts toward individualized medicine have constantly increased in an attempt to improve treatment options. These efforts have led to the development of small molecules which target specific molecular pathways involved in cancer progression. We have reviewed preclinical studies of sunitinib tha...
Saved in:
Main Authors: | Ignacio Segarra (Author), Pilar Modamio (Author), Cecilia Fernández (Author), Eduardo L. Mariño (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical Trials
by: Klaus Rose, et al.
Published: (2015) -
Biologic therapies committee. What does it provide?
by: Virginia Martínez-Santana, et al.
Published: (2021) -
Evolution of ethics in clinical research and ethics committee
by: Nilay Kanti Das, et al.
Published: (2017) -
How to register ethics committee?
by: Amrita Sil, et al.
Published: (2023) -
Jurisdiction of the medical ethics committees
by: Voljč Božidar
Published: (2017)